Friday, 8 February 2019

UniQure gene therapy shows rise in blood-clotting protein in trial

UniQure NV said on Friday its gene therapy to treat patients with a blood disorder, hemophilia B, increased the levels of a protein that helps in blood clotting after 12 weeks.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)